Skip to content

Innovation, Alliances, and the Environment: 2024 Priorities for Drug Manufacturers

Adaptability, global collaboration, supply chain innovation and mRNA technologies were just some of the key trends in 2023. Rephine’s Dr. Eduard Cayón expects these themes to continue to develop and accelerate in 2024.

Innovation, Alliances, and the Environment: 2024 Priorities for Drug Manufacturers
Published: | 5 min read

Shutterstock

Adaptability, global collaboration, supply chain innovation and mRNA technologies were just some of the key trends in 2023. Rephine’s Dr. Eduard Cayón expects these themes to continue to develop and accelerate in 2024, alongside growing pressure to innovate, and increasing focus on unmet clinical needs, commercial alliances and on achieving Net Zero.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information